(Q46395644)

21 December 2017

title

Neurocognitive performance does not correlate with suicidality in schizophrenic and schizoaffective patients at risk for suicide (English)

1 reference

21 December 2017

0 references

0 references

0 references

0 references

1

1 reference

21 December 2017

author name string

Ravi Anand

series ordinal

2

1 reference

21 December 2017

Larry Alphs

series ordinal

3

1 reference

21 December 2017

Kirsten Fleming

series ordinal

4

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

21 December 2017

published in

Schizophrenia Research

1 reference

21 December 2017

volume

59

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

59-66

1 reference

21 December 2017

Assessment of insight in psychosis.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Suicidal behavior in schizophrenia and its relationship to awareness of illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Postmortem findings in suicide victims. Implications for in vivo imaging studies

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Assessment of suicidal intention: The Scale for Suicide Ideation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Mortality in DSM-IIIR schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Characterization of schizophrenic patients who commit suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

TRANQUILIZERS AND SUICIDE IN THE SCHIZOPHRENIC PATIENT.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Rates and correlates of suicide attempts in first-admission psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Insight, neurocognitive function and symptom clusters in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Cognitive improvements in psychotic subjects treated with "Seroquel" (quetiapine fumarate): an exploratory study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Psychological predictors of insight and compliance in psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

A new five factor model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Mortality and causes of death in first admitted schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Mortality in a cohort of patients with schizophrenia: a record linkage study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Neuropsychological function in schizophrenia. Selective impairment in memory and learning

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Mortality in current and former users of clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

Risk for suicide in schizophrenia and other psychotic and nonpsychotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900159-7

7 January 2021

10.1016/S0920-9964(02)00159-7

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017